Does treatment with recombinant human erythropoietin affect the survival of anemic patients with cancer?
Steensma
David P
DP
Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA. steensma.david@mayo.edu
Witzig
Thomas E
TE